OptimizeRx Corp Cash Flow Statement
OPRX|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
OptimizeRx Corp generated $5M in operating cash flow and $5M in free cash flow in FY2025. Free cash flow margin was 5.2% of revenue.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$20.1M | -$17.6M | -$11.4M | $378.1K | -$2.2M | -$3.1M | $226.3K | -$2.1M | -$1.5M | -$595.1K | -$1.0M | -$659.9K | -$454.6K | -$2.1M | -$2.0M |
| Depreciation & Amortization | $4.3M | $2.4M | $2.0M | $2.0M | $2.1M | $1.3M | $316.5K | $324.6K | $235.3K | $333.9K | $264.3K | $193.8K | $187.1K | $145.3K | $59.9K |
| Operating Cash Flow | $4.9M | -$7.2M | $10.7M | $726.0K | -$6.3M | -$1.7M | $792.6K | -$1.5M | -$466.0K | $515.1K | -$56.4K | $1.1M | -$624.0K | -$521.5K | -$1.3M |
| Capital Expenditures | $112.0K | $87.0K | $81.0K | $100.3K | $68.0K | $87.7K | $34.4K | $42.2K | $178.4K | $2.0K | $7.0K | - | $2.2K | $13.1K | -$1.2K |
| Free Cash Flow | $4.8M | -$7.3M | $10.6M | $625.7K | -$6.4M | -$1.7M | $758.2K | -$1.5M | -$644.4K | $513.1K | -$63.3K | - | -$626.3K | -$534.6K | -$1.3M |
| Share Buybacks | - | $7.5M | $20.0M | $20.0M | - | - | - | $390.0K | $806.9K | $0 | $6.0M | $0 | - | - | - |
| FCF Margin | 5.2% | -10.2% | 16.9% | 1.0% | -14.7% | -7.1% | 3.6% | -12.6% | -8.3% | 7.1% | -1.0% | - | -31.5% | -48.1% | -1843.6% |